Annual Operating Profit
-$9.71 M
+$1.35 M+12.25%
31 December 2023
Summary:
Scinai Immunotherapeutics annual operaing income is currently -$9.71 million, with the most recent change of +$1.35 million (+12.25%) on 31 December 2023. During the last 3 years, it has fallen by -$11.99 million (-525.55%). SCNI annual operating profit is now -525.55% below its all-time high of $2.28 million, reached on 01 December 2020.SCNI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.03 M
-$99.00 K-5.13%
30 June 2024
Summary:
Scinai Immunotherapeutics quarterly operating income is currently -$2.03 million, with the most recent change of -$99.00 thousand (-5.13%) on 30 June 2024. Over the past year, it has increased by +$75.00 thousand (+3.57%). SCNI quarterly operating profit is now -112.57% below its all-time high of $16.12 million, reached on 01 September 2020.SCNI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$7.88 M
+$568.00 K+6.72%
30 June 2024
Summary:
Scinai Immunotherapeutics TTM operating income is currently -$7.88 million, with the most recent change of +$568.00 thousand (+6.72%) on 30 June 2024. Over the past year, it has increased by +$3.02 million (+27.74%). SCNI TTM operating profit is now -198.46% below its all-time high of $8.00 million, reached on 01 June 2021.SCNI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.3% | +3.6% | +27.7% |
| 3 y3 years | -525.5% | +20.6% | +26.2% |
| 5 y5 years | +52.6% | +62.7% | +60.2% |
SCNI Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -525.5% | +12.3% | -11.2% | +41.1% | at high | +33.6% |
| 5 y | 5 years | -525.5% | +57.1% | -112.6% | +78.6% | -198.5% | +69.7% |
| alltime | all time | -525.5% | +57.1% | -112.6% | +78.6% | -198.5% | +69.7% |
Scinai Immunotherapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.03 M(+5.1%) | -$7.88 M(-6.7%) |
| Mar 2024 | - | -$1.93 M(+5.8%) | -$8.45 M(-13.0%) |
| Dec 2023 | -$9.71 M(-12.3%) | -$1.82 M(-13.3%) | -$9.71 M(-11.0%) |
| Sept 2023 | - | -$2.10 M(-19.0%) | -$10.90 M(-0.5%) |
| June 2023 | - | -$2.60 M(-18.5%) | -$10.96 M(-5.7%) |
| Mar 2023 | - | -$3.19 M(+5.4%) | -$11.63 M(+5.2%) |
| Dec 2022 | -$11.06 M(+1.8%) | -$3.02 M(+39.8%) | -$11.06 M(-3.7%) |
| Sept 2022 | - | -$2.16 M(-33.8%) | -$11.48 M(-3.3%) |
| June 2022 | - | -$3.26 M(+24.8%) | -$11.88 M(+4.7%) |
| Mar 2022 | - | -$2.62 M(-24.1%) | -$11.35 M(+5.5%) |
| Dec 2021 | -$10.86 M(-576.2%) | - | - |
| Dec 2021 | - | -$3.44 M(+34.8%) | -$10.76 M(+0.7%) |
| Sept 2021 | - | -$2.55 M(-6.6%) | -$10.68 M(-233.4%) |
| June 2021 | - | -$2.73 M(+35.2%) | $8.00 M(+31.8%) |
| Mar 2021 | - | -$2.02 M(-39.9%) | $6.07 M(+144.9%) |
| Dec 2020 | $2.28 M(-110.1%) | -$3.36 M(-120.9%) | $2.48 M(-168.0%) |
| Sept 2020 | - | $16.12 M(-445.5%) | -$3.64 M(-85.5%) |
| June 2020 | - | -$4.67 M(-16.9%) | -$25.20 M(-3.2%) |
| Mar 2020 | - | -$5.62 M(-40.8%) | -$26.04 M(+16.2%) |
| Dec 2019 | -$22.63 M(+10.6%) | -$9.48 M(+74.6%) | -$22.40 M(+13.2%) |
| Sept 2019 | - | -$5.43 M(-1.4%) | -$19.79 M(+23.9%) |
| June 2019 | - | -$5.51 M(+179.0%) | -$15.97 M(-15.2%) |
| Mar 2019 | - | -$1.97 M(-71.3%) | -$18.84 M(-7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$20.46 M(+200.6%) | -$6.87 M(+326.4%) | -$20.46 M(+14.2%) |
| Sept 2018 | - | -$1.61 M(-80.8%) | -$17.91 M(+4.1%) |
| June 2018 | - | -$8.38 M(+133.0%) | -$17.21 M(+79.8%) |
| Mar 2018 | - | -$3.60 M(-16.8%) | -$9.57 M(+40.9%) |
| Dec 2017 | -$6.81 M(+120.0%) | -$4.32 M(+375.3%) | -$6.79 M(+110.6%) |
| Sept 2017 | - | -$909.40 K(+22.4%) | -$3.23 M(-0.5%) |
| June 2017 | - | -$742.90 K(-9.3%) | -$3.24 M(+3.2%) |
| Mar 2017 | - | -$819.10 K(+8.5%) | -$3.14 M(+2.3%) |
| Dec 2016 | -$3.09 M(+6.8%) | -$754.80 K(-18.3%) | -$3.07 M(-8.8%) |
| Sept 2016 | - | -$924.20 K(+43.9%) | -$3.37 M(+12.0%) |
| June 2016 | - | -$642.40 K(-14.3%) | -$3.01 M(-6.5%) |
| Mar 2016 | - | -$749.60 K(-28.7%) | -$3.21 M(+9.9%) |
| Dec 2015 | -$2.90 M(+38.5%) | -$1.05 M(+86.6%) | -$2.92 M(+27.6%) |
| Sept 2015 | - | -$563.20 K(-33.7%) | -$2.29 M(+1.4%) |
| June 2015 | - | -$850.10 K(+84.6%) | -$2.26 M(+10.5%) |
| Mar 2015 | - | -$460.50 K(+9.9%) | -$2.05 M(-5.4%) |
| Dec 2014 | -$2.09 M(-4.7%) | -$419.00 K(-21.2%) | -$2.16 M(-6.2%) |
| Sept 2014 | - | -$531.80 K(-16.3%) | -$2.31 M(-0.5%) |
| June 2014 | - | -$635.60 K(+10.2%) | -$2.32 M(+37.8%) |
| Mar 2014 | - | -$576.90 K(+2.7%) | -$1.68 M(+52.2%) |
| Dec 2013 | -$2.19 M(-10.3%) | -$561.50 K(+3.2%) | -$1.11 M(+103.2%) |
| Sept 2013 | - | -$544.00 K | -$544.00 K |
| Dec 2012 | -$2.44 M(+13.1%) | - | - |
| Dec 2011 | -$2.16 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual operaing income?
- What is the all time high annual operating profit for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual operating profit year-on-year change?
- What is Scinai Immunotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly operating profit year-on-year change?
- What is Scinai Immunotherapeutics TTM operating income?
- What is the all time high TTM operating profit for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM operating profit year-on-year change?
What is Scinai Immunotherapeutics annual operaing income?
The current annual operating profit of SCNI is -$9.71 M
What is the all time high annual operating profit for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual operaing income is $2.28 M
What is Scinai Immunotherapeutics annual operating profit year-on-year change?
Over the past year, SCNI annual operaing income has changed by +$1.35 M (+12.25%)
What is Scinai Immunotherapeutics quarterly operating income?
The current quarterly operating profit of SCNI is -$2.03 M
What is the all time high quarterly operating profit for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly operating income is $16.12 M
What is Scinai Immunotherapeutics quarterly operating profit year-on-year change?
Over the past year, SCNI quarterly operating income has changed by +$75.00 K (+3.57%)
What is Scinai Immunotherapeutics TTM operating income?
The current TTM operating profit of SCNI is -$7.88 M
What is the all time high TTM operating profit for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM operating income is $8.00 M
What is Scinai Immunotherapeutics TTM operating profit year-on-year change?
Over the past year, SCNI TTM operating income has changed by +$3.02 M (+27.74%)